Selected article for: "long heparin and low molecular"

Author: Vitiello, Antonio; Ferrara, Francesco
Title: Low Molecular Weight Heparin, Anti-inflammatory/Immunoregulatory and Antiviral Effects, a Short Update
  • Cord-id: tn20xniw
  • Document date: 2021_8_30
  • ID: tn20xniw
    Snippet: Low molecular weight heparin (LMWH) is a glycosaminoglycan long known for its anticoagulant properties. In recent times, recent evidence has associated this drug with extra pleiotropic anticoagulant effects that have also proven useful in the management of the treatment of COVID-19 infection indicating that heparin may play other roles in the management of the disease in addition to the prevention of thrombosis. Clinical observations and in vitro studies support that heparin has a potential mult
    Document: Low molecular weight heparin (LMWH) is a glycosaminoglycan long known for its anticoagulant properties. In recent times, recent evidence has associated this drug with extra pleiotropic anticoagulant effects that have also proven useful in the management of the treatment of COVID-19 infection indicating that heparin may play other roles in the management of the disease in addition to the prevention of thrombosis. Clinical observations and in vitro studies support that heparin has a potential multi-target effect. To date, the molecular mechanisms of these pleiotropic effects are not fully understood. This brief review presents some of the evidence from clinical and animal studies and describes the potential molecular mechanisms by which heparin may exert its anti-inflammatory/immunoregulatory and antiviral effects.

    Search related documents:
    Co phrase search for related documents
    • abnormal inflammatory response and low molecular weight heparin: 1
    • acetylsalicylic acid and lmwh low molecular weight heparin: 1, 2
    • acetylsalicylic acid and lmwh treatment: 1
    • acetylsalicylic acid and low molecular weight: 1, 2, 3, 4, 5
    • acetylsalicylic acid and low molecular weight heparin: 1, 2, 3, 4
    • acute condition and adhesion molecule: 1, 2
    • acute condition and low molecular weight: 1
    • acute condition and low molecular weight heparin: 1